Comparison

Remogliflozin etabonate European Partner

Item no. TMO-T34286-500mg
Manufacturer TargetMol
CASRN 442201-24-3
Amount 500 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C26H38N2O9
Smiles CCOC(=O)OC[C@H]1O[C@@H](Oc2nn(C(C)C)c(C)c2Cc2ccc(OC(C)C)cc2)[C@H](O)[C@@H](O)[C@@H]1O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias GSK189075,GSK 189075,GSK-189075A,GSK189075A,GSK-189075,GSK 189075A
Shipping Condition Cool pack
Available
Manufacturer - Targets
SGLT
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
522.59
Description
Remogliflozin etabonate (GSK189075A) is a prodrug of regaliflozin and an inhibitor SGLT2 with Ki values of 1.95, 2.14, 8.57, and 43.1μM for hSGLT2, rSGLT2, rSGLT1, and hSGLT1, respectively.
Pathways
GPCR/G Protein
Bioactivity
Remogliflozin etabonate (GSK 189075A, GSK 189075) is an SGLT2 inhibitor, the prodrug of regaliflozin. Remogliflozin inhibits the sodium-glucose transporter (SGLT), which are responsible for glucose reabsorption in the kidney. Blocking this transporter cau

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close